How targeted therapies are boosting outcomes for bone marrow cancer ...Middle East

News room odisha - News
How targeted therapies are boosting outcomes for bone marrow cancer
New Delhi, Sep 30 (IANS) Patients with chronic myeloid leukaemia (CML) — a type of cancer of the bone marrow — are seeing better outcomes with targeted therapies, said experts on Monday. CML is a slow-growing cancer that affects the bone marrow and blood. The US National Institute of Health (US) estimates that 1.2 to 1.5 million people worldwide are living with CML. The cancer has seen a notable rise in India, in recent years, with a typical diagnosis occurring in individuals aged 30-40 years. According to data from Indian cancer registries, CML is the most common type of leukaemia diagnosed in the country. A previous study reported the annual incidence of CML in India to be 0.8 to 2.2 per 1

Hence then, the article about how targeted therapies are boosting outcomes for bone marrow cancer was published today ( ) and is available on News room odisha ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( How targeted therapies are boosting outcomes for bone marrow cancer )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News